Clinical Trial Update: Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Reports results of a pharmacokinetic/pharmacodynamic study of MP-513 in patients with Type 2 Diabetes Mellitus conducted in Phase 3, with results posted in 2012…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MP-513

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2012-12-19